U.S. Markets open in 1 hr 19 mins

BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

SAN JOSE, Calif. , March 18, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences.

(PRNewsfoto/BioPharmX Corporation)

President and CEO Dr. David S. Tierney will present the latest company overview at:

  • The 31 st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA.
  • The Oppenheimer 29 th Annual Healthcare Conference on Wednesday, March 20, 2019 at 1:00pm Eastern Time in New York, NY .

About BioPharmX® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX™ Topical Delivery System for dermatology indications. To learn more about BioPharmX, visit www.BioPharmX.com .


View original content to download multimedia: http://www.prnewswire.com/news-releases/biopharmx-to-participate-in-the-31st-annual-roth-conference-and-the-oppenheimer-29th-annual-healthcare-conference-300813694.html